Latest News
InMed Stock Retreats After 135% Merger Rally; Deal Dilution Weighs
InMed Pharmaceuticals shares fell 14.4% in pre-market trading Wednesday, giving back some of Tuesday's 135% surge on news of an all-stock merger with Mentari Therapeutics and a $290 million private placement.
Micware Stock Rebounds in Premarket After Nasdaq Debut Plunge
Micware shares rebounded sharply in premarket trading Wednesday, nearly doubling after a steep decline on its Nasdaq debut. Toyota disclosed an 11.6% stake in the company.
Futures Edge Up as Markets Await Nvidia Earnings and Fed Minutes
U.S. stock futures edged higher early Wednesday as traders braced for Nvidia's earnings after the close and the release of Fed minutes.
Houston Grid Woes Continue as CenterPoint Investigates Bear Creek Outages
Bear Creek residents in Houston report ongoing power outages and surges damaging appliances and medication, prompting CenterPoint Energy to investigate as hurricane season nears.
Bolt CEO Defends HR Shutdown, Says Smaller Team Boosts Agility
Bolt CEO Ryan Breslow defended cutting the HR department at Fortune's summit, stating it created problems. The move follows layoffs and a shift to AI and a finance app.
CPS Energy Breaks Ground on 120MW Battery as Outage Times Worsen
CPS Energy and OCI Energy have started building a 120MW battery storage facility in Bexar County, targeting 2027 operations. The project comes as average outage times for CPS customers rose to 75.38 minutes.
Co-Diagnostics Shares Slip After $3M Placement, Ebola Assay News
Co-Diagnostics shares declined after the company disclosed a $3 million private placement, following a sharp rally on Ebola test development news.
Micron Gains Amid Tech Selloff; Samsung Strike May Tighten Memory Supply
Micron shares gained 2.5% on Tuesday, reaching $698.74, as the Nasdaq fell. A planned Samsung strike could tighten memory supply and drive prices higher.
Intel Surges on Analyst Optimism Over AI Server CPU Demand
Intel shares rebounded 2.43% to $110.80 on Tuesday, snapping a five-day decline, as analysts boosted price targets on AI server CPU demand. The stock faces key tests from Nvidia earnings and foundry challenges.
